Nautilus Biotechnolgy (NAUT) Revenue & Revenue Breakdown
Nautilus Biotechnolgy Revenue Highlights
0
Latest Revenue (Q)
$190.00K
Nautilus Biotechnolgy Revenue by Period
Nautilus Biotechnolgy Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Nautilus Biotechnolgy generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Nautilus Biotechnolgy Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $190.00K | 100.00% |
| 2026-03-31 | - | 100.00% |
| 2025-12-31 | - | 100.00% |
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | - |
Nautilus Biotechnolgy generated $190.00K in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Nautilus Biotechnolgy Revenue Breakdown
Nautilus Biotechnolgy Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 26 |
|---|---|
| Service Revenue | $15.00K |
| Grant Revenue | $180.00K |
Latest
Nautilus Biotechnolgy's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Grant Revenue (92.31%), and Service Revenue (7.69%).
Nautilus Biotechnolgy Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ARCT | Arcturus Therapeutics | $82.03M | $2.96M |
| ENTA | Enanta Pharmaceuticals | $65.32M | $14.36M |
| FHTX | Foghorn Therapeutics | $30.91M | $16.07M |
| PYXS | Pyxis Oncology | $13.86M | - |
| HUMA | Humacyte | $2.04M | $406.00K |
| IMRX | Immuneering | - | $360.96K |
| ZURA | Zura Bio | - | - |
| TNYA | Tenaya Therapeutics | - | $1.11M |
| NAUT | Nautilus Biotechnolgy | - | $190.00K |
| ASMB | Assembly Biosciences | - | - |
| SGMT | Sagimet Biosciences | - | - |